SI
IONS icon

Scout Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Scout Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-258,813
Closed -$15.6M – 297
2019
Q4 		$15.6M Buy
+258,813
New +$15.4M 0.3% 116
2019
Q3 		– Sell
-81,088
Closed -$5.21M – 281
2019
Q2 		$5.21M Sell
81,088
-216,727
-73% -$15.3M 0.1% 204
2019
Q1 		$24.2M Sell
297,815
-74,214
-20% -$4.79M 0.5% 64
2018
Q4 		$20.1M Buy
372,029
+2,044
+0.6% +$104K 0.51% 61
2018
Q3 		$19.1M Buy
369,985
+667
+0.2% +$31.3K 0.39% 109
2018
Q2 		$15.4M Buy
369,318
+39,498
+12% +$1.75M 0.35% 125
2018
Q1 		$14.5M Buy
329,820
+244,155
+285% +$12.4M 0.35% 129
2017
Q4 		$4.31M Sell
85,665
-58,177
-40% -$3.19M 0.11% 200
2017
Q3 		$7.29M Buy
143,842
+5,297
+4% +$277K 0.2% 154
2017
Q2 		$7.05M Sell
138,545
-174,657
-56% -$8.13M 0.2% 154
2017
Q1 		$12.6M Sell
313,202
-111,444
-26% -$5.01M 0.35% 134
2016
Q4 		$20.3M Buy
424,646
+140,710
+50% +$5.57M 0.57% 62
2016
Q3 		$10.4M Sell
283,936
-122,209
-30% -$3.82M 0.29% 131
2016
Q2 		$9.46M Buy
406,145
+308,284
+315% +$9.94M 0.26% 127
2016
Q1 		$3.96M Sell
97,861
-81,638
-45% -$3.32M 0.11% 162
2015
Q4 		$11.1M Buy
179,499
+18,423
+11% +$994K 0.28% 123
2015
Q3 		$6.51M Sell
161,076
-88,453
-35% -$4.58M 0.15% 142
2015
Q2 		$14.4M Sell
249,529
-99,069
-28% -$6.3M 0.27% 122
2015
Q1 		$22.2M Buy
348,598
+177,067
+103% +$12M 0.37% 106
2014
Q4 		$10.6M Sell
171,531
-352,716
-67% -$17.4M 0.16% 127
2014
Q3 		$20.4M Sell
524,247
-305,451
-37% -$10.8M 0.27% 106
2014
Q2 		$28.6M Sell
829,698
-37,554
-4% -$1.18M 0.33% 96
2014
Q1 		$37.5M Buy
+867,252
New +$42M 0.43% 76

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Scout Investments's IONS Position: Q1 2020 in Review

Scout Investments sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 258,813 shares — an estimated $15.6M sold.

Scout Investments first reported a position in IONS in Q1 2014 and held it in 23 quarters. The position peaked at $37.5M in Q1 2014. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

  • Scout Investments reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Scout Investments sold 258,813 Ionis Pharmaceuticals shares in Q1 2020, an estimated $15.6M.
  • Scout Investments first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 23 quarters.
  • Scout Investments's Ionis Pharmaceuticals position peaked at $37.5M in Q1 2014.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Scout Investments's 13F filing for Q1 2020, filed 16 Apr 2020.